Immunocore Holdings plc

IMCR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $1.4B · 524 employees
84
SEC Filings
$29.56
Close 2026-06-02
524
Employees

Business Summary

EX-31.1 4 imcr-20231231xex31x11.htm EX-31.1 Document Exhibit 31.1 Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Bahija Jallal, certify that 1. I have reviewed this Annual Report on Form 10-K of Immunocore Holdings plc 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to ...

Latest Stock Quote

IMCR 2026-06-02 $29.56 O:$28.61 H:$29.73 L:$28.04 Vol:0.6M VWAP:$28.8007
origin leaf: eb10f6ff2a275d0cfd0a88a8f5ad2fd406e05d299d80e56f6061ff994ca0bec9

Next Earnings

Q2 FY2026 — expected 2026-08-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001671927-26-000005EDGAR110K words
2025-02-262024-12-310001671927-25-000006EDGAR—
2024-02-282023-12-310001140361-24-009921EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001671927-25-000018EDGAR21K words
2025-08-072025-06-300001671927-25-000014EDGAR—
2025-05-072025-03-310001671927-25-000009EDGAR—
2024-11-062024-09-300001671927-24-000011EDGAR—
2024-08-082024-06-300001671927-24-000005EDGAR—
2024-05-082024-03-310001140361-24-024784EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-250001140361-26-006721EDGAR5K words
2026-01-300001140361-26-002894EDGAR—
2026-01-090001140361-26-000780EDGAR—
2025-11-280001140361-25-043600EDGAR—
2025-11-060001140361-25-040664EDGAR—
2025-08-070001140361-25-029350EDGAR—
2025-05-150001140361-25-019282EDGAR—
2025-05-070001140361-25-017615EDGAR—
2025-03-170001140361-25-008918EDGAR—
2025-03-100001140361-25-007867EDGAR—

84 total filings indexed. 65 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001671927
TickerIMCR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedX0
Websitehttps://www.immunocore.com
Listed2021-02-05

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 122c50e713418576015eba94383a37f22f576ade46ee71e5542c2ddc65ef2e4c
parent: dcfb44cf72bbc3f828deb18eb1ddfb2368946010c15f4b334e995a0f1ed689c7
content hash: 34f4a03524f8b06f64a38595a4f6f02a981a75f7f2351a980ee79f40d6b6fc72
signed: 2026-06-03T12:01:29.114Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf